Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis

[1]  N. Mukaida,et al.  Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by interleukin-1 receptor antagonist IL-1Ra , 2019, Nature Microbiology.

[2]  Randle Aaron M. Villanueva,et al.  ggplot2: Elegant Graphics for Data Analysis (2nd ed.) , 2019, Measurement: Interdisciplinary Research and Perspectives.

[3]  Jing-Wen Lin,et al.  Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases , 2019, Nature Communications.

[4]  Benjamin M. C. Swift,et al.  A novel high sensitivity bacteriophage-based assay identifies low level M. tuberculosis bacteraemia in immunocompetent patients with active and incipient TB. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Jason D. Buenrostro,et al.  The cis-Regulatory Atlas of the Mouse Immune System , 2019, Cell.

[6]  K. Ley,et al.  Neutrophils: New insights and open questions , 2018, Science Immunology.

[7]  Mark M. Davis,et al.  A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes , 2018, Nature.

[8]  N. Mukaida,et al.  Interleukin-1 receptor antagonist mediates type I interferon-driven susceptibility to Mycobacterium tuberculosis , 2018, bioRxiv.

[9]  A. Sher,et al.  Type I interferons in tuberculosis: Foe and occasionally friend , 2018, The Journal of experimental medicine.

[10]  S. Horswell,et al.  Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis , 2018, Proceedings of the National Academy of Sciences.

[11]  R. Wilkinson,et al.  A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection , 2017, bioRxiv.

[12]  John L. Johnson,et al.  Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease , 2017, PLoS pathogens.

[13]  H. Mollenkopf,et al.  Concordant and discordant gene expression patterns in mouse strains identify best-fit animal model for human tuberculosis , 2017, Scientific Reports.

[14]  C. Weaver,et al.  T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection , 2017, The Journal of Immunology.

[15]  T. Jiang,et al.  Inference of immune cell composition on the expression profiles of mouse tissue , 2017, Scientific Reports.

[16]  V. Pascual,et al.  The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis , 2016, PloS one.

[17]  D. Lauffenburger,et al.  A Functional Role for Antibodies in Tuberculosis , 2016, Cell.

[18]  Måns Magnusson,et al.  MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..

[19]  Daniel E. Zak,et al.  A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.

[20]  J. Banchereau,et al.  A 380-gene meta-signature of active tuberculosis compared with healthy controls , 2016, European Respiratory Journal.

[21]  G. Beamer,et al.  Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies , 2015, Seminars in Immunopathology.

[22]  M. Gonzalez-Juarrero,et al.  Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis , 2015, Disease Models & Mechanisms.

[23]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[24]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[25]  A. Casadevall,et al.  B cells and antibodies in the defense against Mycobacterium tuberculosis infection , 2015, Immunological reviews.

[26]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[27]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[28]  A. Sher,et al.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk , 2014, Nature.

[29]  H. Mollenkopf,et al.  Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics , 2014, European journal of immunology.

[30]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[31]  A. Sher,et al.  Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway , 2013, The Journal of infectious diseases.

[32]  M. Selman,et al.  S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. , 2013, American journal of respiratory and critical care medicine.

[33]  Michael Levin,et al.  Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control Study , 2013, PLoS medicine.

[34]  T. Ottenhoff,et al.  A Helicopter Perspective on TB Biomarkers: Pathway and Process Based Analysis of Gene Expression Data Provides New Insight into TB Pathogenesis , 2013, PloS one.

[35]  D. Chaussabel,et al.  TPL-2–ERK1/2 Signaling Promotes Host Resistance against Intracellular Bacterial Infection by Negative Regulation of Type I IFN Production , 2013, The Journal of Immunology.

[36]  V. Pascual,et al.  Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers , 2013, PloS one.

[37]  J. Thakar,et al.  Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations , 2013, Nucleic acids research.

[38]  J. Pedrosa,et al.  Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response , 2013, PloS one.

[39]  S. Basu,et al.  Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. , 2013, American journal of respiratory and critical care medicine.

[40]  Robert J Wilkinson,et al.  The immune response in tuberculosis. , 2013, Annual review of immunology.

[41]  J. Casanova,et al.  Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency , 2012, Science.

[42]  B. Nandi,et al.  Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection , 2011, The Journal of experimental medicine.

[43]  A. Sher,et al.  Role of innate cytokines in mycobacterial infection , 2011, Mucosal Immunology.

[44]  B. Nandi,et al.  Regulation of Neutrophils by Interferon-\(\gamma\) Limits Lung Inflammation During Tuberculosis Infection , 2011 .

[45]  D Repsilber,et al.  Human gene expression profiles of susceptibility and resistance in tuberculosis , 2011, Genes and Immunity.

[46]  S. Behar,et al.  Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.

[47]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[48]  A. Sher,et al.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. , 2010, The Journal of clinical investigation.

[49]  H. Mollenkopf,et al.  The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.

[50]  Sang-Nae Cho,et al.  Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. , 2010, Chest.

[51]  J. Flynn,et al.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.

[52]  L. Kobzik,et al.  Immunopathology and Infectious Diseases Dominant Role of the sst 1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts , 2010 .

[53]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[54]  D. Koller,et al.  The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.

[55]  Bin Zhang,et al.  Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..

[56]  I. Orme,et al.  The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.

[57]  Andy M. Yip,et al.  Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.

[58]  A. Sher,et al.  NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis , 2006, The Journal of Immunology.

[59]  S. Ehlers,et al.  Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice , 2006, The Journal of pathology.

[60]  G. Kaplan,et al.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[61]  A. Apt,et al.  Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice , 2005, Infection and Immunity.

[62]  J. Casanova,et al.  Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.

[63]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[64]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[65]  S. Ehlers,et al.  Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung , 2000, Infection and Immunity.

[66]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[67]  C. Dolea,et al.  World Health Organization , 1949, International Organization.